Isoquinoline derivatives Amb4269951 and Amb4269675, discovered through exploratory studies using a library of plant-derived natural organic compounds, are novel potential compounds for the treatment of pancreatic cancer with CTL1 inhibition. Here, SLC44A1 is linked to pancreatic neoplasm.